胰岛素调节Aβ1-42聚合到非有毒的形式:与cis-[Ru(phen) 2(3,4Apy) 22进行比较研究
Marco A Tiburcio1, Bárbara Patrícia N Silva1, Maria Laura da C Garcia1
1Department of Chemistry, Federal University of São Carlos, São Carlos, SP, Brazil.
Journal of inorganic biochemistry
|January 11, 2026
概括
鼻内胰岛素治疗通过促进非有毒的粉样蛋白-β (Aβ) 聚合,对阿尔茨海默病 (AD) 是有前途的. 这种方法针对特定的结合部位,为AD提供了一种新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 材料科学 材料科学 材料科学
背景情况:
- 阿尔茨海默病 (AD) 的特点是粉样蛋白-β (Aβ) 聚合.
- 内胰岛素治疗正在研究其调节Aβ病理的潜力.
- 提出了胰岛素和复合体 (Ru3,4Apy) 与Aβ寡合体的明显结合相互作用.
研究的目的:
- 研究由胰岛素和Ru3,4Apy.调节的Aβ聚合的独特分子机制.
- 了解这些药物如何影响Aβ诱导的细胞毒性.
- 探索针对AD治疗的特定Aβ结合位点的潜力.
主要方法:
- 使用Tyr10内在光,圆形二元化和原子力显微镜监测Aβ1−42聚合.
- 在Aβ1−42,胰岛素和Ru3,4Apy.存在的情况下评估SH-SY5Y细胞活力.
- 使用分子动力学模拟来理解结合相互作用.
主要成果:
- Ru3,4Apy减少了β-片的形成,但没有减轻Aβ1−42诱导的细胞毒性.
- 胰岛素限制了形状灵活性,阻止了Tyr10的埋葬,抑制了β片的形成,并促进了无毒的聚合物.
- 同时服用Aβ1−42,Ru3,4Apy和胰岛素导致一种非有毒的聚合途径.
结论:
- 胰岛素特别与Aβ1−42相互作用,促进非有毒的聚合.
- 针对Aβ的定义结合位点是阿尔茨海默病的一种有前途的治疗策略.
- 这些发现突出了胰岛素和Ru3,4Apy对Aβ聚合和细胞毒性的独特影响.
相关概念视频
Insulin: Biosynthesis, Chemistry, and Preparation
1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K
Insulin: The Receptor and Signaling Pathways
2.7K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.7K


